CT Financial Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

CT Financial Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-820	Closed	-$43.8K	–	672
2016 Q1	$43.8K	Hold	820	–	–	0.02%	307
2015 Q4	$92.6K	Sell	820 -500	-38%	-$55.1K	0.05%	215
2015 Q3	$155K	Hold	1,320	–	–	0.1%	165
2015 Q2	$102K	Buy	1,320 +1,220	+1,220%	+$80K	0.06%	219
2015 Q1	$5.79K	Buy	+100	New	+$4.25K	﹤0.01%	514
2014 Q1	$5.79K	Buy	+100	New	+$1.94K	﹤0.01%	514

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

CT Financial Advisors's ANAC Position: Q2 2016 in Review

CT Financial Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 820 shares — an estimated $43.8K sold.

CT Financial Advisors first reported a position in ANAC in Q1 2014 and held it in 6 quarters. The position peaked at $155K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

CT Financial Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
CT Financial Advisors sold 820 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $43.8K.
CT Financial Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 6 quarters.
CT Financial Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $155K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on CT Financial Advisors's 13F filing for Q2 2016, filed 7 Jul 2016.